Sensitivity of the ViroSeq HIV-1 Genotyping System for Detection of the K103N Resistance Mutation in HIV-1 Subtypes A, C, and D
- 1 September 2006
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 8 (4), 430-432
- https://doi.org/10.2353/jmoldx.2006.050148
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nevirapine (NVP) Resistance in Women with HIV‐1 Subtype C, Compared with Subtypes A and D, after the Administration of Single‐Dose NVPThe Journal of Infectious Diseases, 2005
- Sensitive Drug‐Resistance Assays Reveal Long‐Term Persistence of HIV‐1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single‐Dose NVP: HIVNET 012The Journal of Infectious Diseases, 2005
- Emergence of Drug‐Resistant HIV‐1 after Intrapartum Administration of Single‐Dose Nevirapine Is Substantially UnderestimatedThe Journal of Infectious Diseases, 2005
- Sensitivity and Specificity of the ViroSeq Human Immunodeficiency Virus Type 1 (HIV-1) Genotyping System for Detection of HIV-1 Drug Resistance Mutations by Use of an ABI PRISM 3100 Genetic AnalyzerJournal of Clinical Microbiology, 2005
- LigAmp for sensitive detection of single-nucleotide differencesNature Methods, 2004
- Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African SettingJAMA, 2004
- Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 StrainsJournal of Clinical Microbiology, 2004
- Characterization of Nevirapine Resistance Mutations in Women With Subtype A Vs. D HIV-1 6???8 Weeks After Single-Dose Nevirapine (HIVNET 012)JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trialThe Lancet, 2003
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999